Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Pharmaceuticals filed suit against VGXI, a subsidiary of South Korea’s GeneOne Life Sciences, last month, accusing it of not transferring technical details pertaining to manufacturing doses of INO-4800, Inovio’s DNA vaccine compound with promising results against SARS-CoV-2. Inovio details in the lawsuit that VGXI does not possess the capacity to scale up manufacturing, which is essential … Read more

Synthetic Biology Features Prominently In Pershing Square Foundation’s Recent Funding Awards To Fight SARS-CoV-2 Virus

The Pershing Square Foundation recently announced that it has awarded $3 million to nineteen recipients at ten academic research institutions in furtherance of conducting research related to the SARS-CoV-2 virus. As scientists across various disciplines around the world have risen to the challenge of combating SARS-CoV-2, The Pershing Square Foundation (the “Foundation”) worked with its … Read more

IPO: Yield10 Bioscience, Inc

IPO: Yield10 Bioscience, Inc

Global food security is a big concept for a small company. To achieve its lofty goals, Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yields. The company has an extensive track record of innovation based around optimizing the flow of carbon in living systems, and it is leveraging … Read more

Invitae And ArcherDX Join Forces To Expand Cancer Genetics And Precision Oncology

Invitae And ArcherDX Join Forces To Expand Cancer Genetics And Precision Oncology

Invitae (NYSE: NVTA), a leading genetics and synthetic biology company, and ArcherDX, a leading genomics analysis company innovating in precision oncology, today announced the companies have entered into an agreement to combine. The combined company aims to advance care for cancer patients by accelerating adoption of genetics . Integrating germline testing, tumor profiling and liquid biopsy … Read more

FDA Issues Breakthrough Device Designation To New Device For Detection of NTRK fusions

FDA Issues Breakthrough Device Designation To New Device For Detection of NTRK fusions

ArcherDX, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a companion diagnostic (CDx) to detect neurotrophic receptor tyrosine kinase (NTRK) gene fusions that lead to the formation and growth of cancer. ArcherDX’s NGS technology utilizes proprietary Anchored Multiplex PCR … Read more

KcKinsey’s Bio Revolution Study Targets $4 Trillion Impact

KcKinsey’s Bio Revolution Study Targets $4 Trillion Impact

Advances in biological sciences, accelerated by computing, automation, and artificial intelligence (AI), is fueling a new wave of innovation that will impact economies and societies that will surpass the industrial revolution. In fact, these new capabilities and applications are already improving our response to global challenges from climate change to pandemics. But these innovations come … Read more